| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |